Results for "Seizures"
Conditions Encyclopedia Entry 1776775275
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. MM can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely depending on the specific type of disorder and the severity of the mutation. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation, which is not inherited from either parent. The diagnosis of MM is often challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of genetic testing, muscle biopsy, and other diagnostic tests. ### History/Background Mitochondrial Myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of the disorder was understood. In 1988, a team of researchers discovered that a mutation in the mitochondrial DNA was responsible for a specific type of MM. Since then, numerous other mutations have been identified as causing MM. The understanding of MM has improved significantly over the years, and researchers are working to develop new treatments and therapies for the disorder. ### Key Information Mitochondrial Myopathies are a group of disorders that affect the mitochondria, the energy-producing structures within cells. There are several types of MM, including: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a disorder that affects the brain, muscles, and other organs. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder that affects the brain and muscles. * **Kearns-Sayre Syndrome (KSS)**: a disorder that affects the muscles, heart, and other organs. * **NARP Syndrome (Neuropathy, Ataxia, and Retinitis Pigmentosa)**: a disorder that affects the nervous system, muscles, and eyes. The symptoms of MM can vary widely depending on the specific type of disorder and the severity of the mutation. Common symptoms include: * Muscle weakness and wasting * Fatigue and muscle pain * Numbness or tingling in the hands and feet * Vision loss * Hearing loss * Seizures and epilepsy * Stroke-like episodes ### Significance Mitochondrial Myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders can have a significant impact on the quality of life for those affected, and can be life-threatening in some cases. Researchers are working to develop new treatments and therapies for MM, including gene therapy and other experimental treatments. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first described) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Genetic disorder, Mitochondria, Energy production, Muscle weakness, Fatigue, Numbness, Vision loss, Hearing loss, Seizures, Epilepsy, Stroke-like episodes, Gene therapy, Experimental treatments.
Health & MedicineConditions Encyclopedia Entry 1777409054
** This encyclopedia entry provides an in-depth look at **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare, inherited disorders that affect the mitochondria, the energy-producing structures within cells. MMs are characterized by the accumulation of mutations in the mitochondrial DNA (mtDNA), leading to impaired energy production and cellular dysfunction. This results in a range of symptoms, including muscle weakness, fatigue, and other systemic problems. MMs are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition, and it is usually passed down from the mother. Mitochondrial Myopathies are a diverse group of disorders, with over 150 different mutations identified in the mtDNA. The most common forms of MMs include **Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**, **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**, and **Kearns-Sayre Syndrome (KSS)**. Each of these conditions has distinct clinical features and age of onset, but they all share a common underlying defect in mitochondrial function. ## History/Background The study of Mitochondrial Myopathies dates back to the 1960s, when the first cases were described in the medical literature. However, it wasn't until the 1980s that the genetic basis of these disorders was identified. The discovery of the first mitochondrial DNA mutation in 1988 marked a significant turning point in the field, and since then, numerous studies have shed light on the molecular mechanisms underlying MMs. Today, MMs are recognized as a distinct group of disorders, with a growing body of research focused on understanding their pathophysiology and developing effective treatments. ## Key Information * **Prevalence:** MMs are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. * **Causes:** MMs are caused by mutations in the mitochondrial DNA, which are inherited from the mother. * **Symptoms:** Symptoms of MMs can vary widely, but often include muscle weakness, fatigue, seizures, and other systemic problems. * **Diagnostic tests:** Diagnosis is typically made using a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment:** There is no cure for MMs, but treatment options include medications to manage symptoms, physical therapy, and lifestyle modifications. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. MMs also underscore the complex interplay between genetic and environmental factors in disease development. Furthermore, the study of MMs has led to a greater understanding of the role of mitochondria in various diseases, including neurodegenerative disorders and cancer. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first cases described) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial Myopathies, Mitochondrial DNA, Genetic disorder, Muscle weakness, Fatigue, Seizures, Rare disease, Neurodegenerative disorder, Cancer.
Health & MedicineConditions Encyclopedia Entry 1778756960
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a collection of rare, inherited disorders that affect the mitochondria, the powerhouses of cells. These disorders are caused by mutations in mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including muscles, the nervous system, and other organs. Symptoms can vary widely among individuals, but often include muscle weakness, fatigue, and pain. Mitochondrial myopathies are often inherited in a maternal lineage, meaning that they are passed down from mother to child. This is because only egg cells contribute mitochondria to the fertilized egg, while sperm cells do not. As a result, mitochondrial DNA is inherited solely from the mother. The disorders can be caused by mutations in any of the 37 genes found in mitochondrial DNA, which are responsible for encoding proteins involved in energy production. ## History/Background The first reported case of mitochondrial myopathy was in 1962, when a British neurologist named Keith Killen described a family with a rare disorder affecting the muscles and nervous system. However, it wasn't until the 1980s that the genetic basis of the disorder was identified. In 1988, a team of researchers led by Douglas C. Wallace discovered that the disorder was caused by a mutation in mitochondrial DNA. This breakthrough led to a greater understanding of the role of mitochondria in human disease and paved the way for the development of new treatments. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: - **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), which is a weakness of the eye muscles. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by seizures and muscle weakness. - **NARP Syndrome**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. - **Leigh Syndrome**: a disorder characterized by progressive brain damage and muscle weakness. Symptoms of mitochondrial myopathies can vary widely among individuals, but often include: - Muscle weakness and fatigue - Pain and stiffness in the muscles - Difficulty walking or maintaining balance - Seizures and epilepsy - Vision problems, including blindness - Hearing loss - Cognitive impairment and dementia ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and impact on affected individuals and families. While there is currently no cure for these disorders, researchers are working to develop new treatments, including gene therapy and mitochondrial-targeted antioxidants. Understanding the genetic basis of mitochondrial myopathies has also led to a greater appreciation of the importance of mitochondria in human health and disease. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1962 (first reported case) - Location: Worldwide - Known For: Rare inherited disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Inherited Disorders, Muscle Weakness, Fatigue, Pain, Seizures, Epilepsy, Vision Problems, Hearing Loss, Cognitive Impairment.
Health & MedicineConditions Encyclopedia Entry 1778737984
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. MMs are characterized by muscle weakness, fatigue, and other symptoms related to impaired energy production. The disorders can affect individuals of any age, but they are more common in women due to the way mitochondria are inherited. Mitochondrial Myopathies are often classified into several subtypes, including: - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: characterized by muscle spasms, seizures, and other neurological symptoms. - **Kearns-Sayre Syndrome (KSS)**: characterized by progressive external ophthalmoplegia, heart block, and other systemic symptoms. - **NARP Syndrome**: characterized by neuropathy, ataxia, and retinitis pigmentosa. - **MELAS Syndrome**: characterized by mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes. ## History/Background The first reported case of a mitochondrial myopathy was in 1965, when a British physician, **John Morgan Hughes**, described a patient with progressive external ophthalmoplegia. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. The discovery of the mitochondrial DNA and its role in energy production led to a greater understanding of the pathophysiology of MMs. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which can be inherited from either parent. The disorders can be classified into several subtypes based on the specific mutation and the symptoms presented. Some common symptoms of MMs include: - Muscle weakness and fatigue - Muscle pain and cramping - Seizures and other neurological symptoms - Vision loss and eye problems - Heart problems and arrhythmias - Gastrointestinal problems ## Significance Mitochondrial Myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular energy production. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these conditions. While there is currently no cure for MMs, various treatments are available to manage symptoms and slow disease progression. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1965 (first reported case) - **Location:** Worldwide - **Known For:** Impaired energy production in cells ## Tags: Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Seizures, Vision Loss, Heart Problems, Gastrointestinal Problems, Genetic Testing, Counseling.
Health & MedicineConditions Encyclopedia Entry 1779404584
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. These conditions affect the mitochondria's ability to generate energy, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies can affect individuals of any age, from infancy to adulthood, and can be inherited in an autosomal dominant, autosomal recessive, or maternal pattern. Mitochondrial myopathies are often characterized by a combination of muscle weakness, fatigue, and other symptoms, such as seizures, developmental delays, and vision and hearing loss. The severity and progression of the condition can vary widely depending on the specific mutation and the individual's overall health. In some cases, mitochondrial myopathies can be life-threatening, requiring aggressive treatment and management. ### History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and other systemic symptoms. However, it wasn't until the 1980s that the genetic basis of these conditions was discovered, with the identification of mutations in the mitochondrial DNA. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying mitochondrial myopathies, leading to a better understanding of these complex conditions. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which can be inherited in an autosomal dominant, autosomal recessive, or maternal pattern. The most common mutations associated with mitochondrial myopathies include: * **MELAS syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes): a condition characterized by muscle weakness, seizures, and stroke-like episodes. * **MERRF syndrome** (Myoclonic Epilepsy with Ragged-Red Fibers): a condition characterized by muscle weakness, seizures, and progressive muscle wasting. * **KSS syndrome** (Kearns-Sayre Syndrome): a condition characterized by muscle weakness, heart problems, and vision loss. ### Significance Mitochondrial myopathies are a significant public health concern, affecting individuals and families worldwide. These conditions can have a profound impact on quality of life, requiring aggressive treatment and management to manage symptoms and prevent complications. Advances in genetic testing and molecular diagnostics have improved diagnosis and treatment options, but more research is needed to better understand the underlying mechanisms and develop effective therapies. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic Disorders - Date: 1960s (first descriptions) - Location: Global - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Seizures, Developmental Delays, Vision and Hearing Loss, MELAS Syndrome, MERRF Syndrome, KSS Syndrome. **Seeking Professional Care:** If you or a family member is experiencing symptoms of mitochondrial myopathies, it is essential to seek medical attention from a qualified healthcare professional. Early diagnosis and treatment can significantly improve quality of life and prevent complications. Consult a geneticist, neurologist, or other specialist for proper evaluation and management.
Health & MedicineConditions Encyclopedia Entry 1780703345
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA. These conditions affect the mitochondria, the energy-producing structures within cells, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. Mitochondrial Myopathies are often inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene is enough to cause the condition. The symptoms and severity of MM can vary widely among affected individuals, even within the same family. Mitochondrial Myopathies are a complex and multifaceted group of disorders, and diagnosis can be challenging. A combination of clinical evaluation, genetic testing, and muscle biopsy may be necessary to confirm the diagnosis. Treatment options are limited, and management typically focuses on symptom relief and supportive care. ### History/Background The first reported cases of Mitochondrial Myopathies date back to the 1960s, when researchers identified a group of patients with unusual muscle disorders. Over the years, advances in genetic testing and molecular biology have led to a better understanding of the underlying causes of MM. In 1988, the first mitochondrial DNA mutation associated with MM was identified, and since then, numerous other mutations have been discovered. ### Key Information **Types of Mitochondrial Myopathies:** 1. **Kearns-Sayre Syndrome (KSS):** A rare condition characterized by progressive external ophthalmoplegia, muscle weakness, and other systemic problems. 2. **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF):** A condition associated with myoclonic seizures, muscle weakness, and other neurological symptoms. 3. **Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP):** A rare condition characterized by progressive neuropathy, ataxia, and retinitis pigmentosa. **Symptoms and Complications:** * Muscle weakness and fatigue * Muscle pain and cramping * Seizures and other neurological symptoms * Vision loss and blindness * Hearing loss and deafness * Cardiac problems and arrhythmias * Respiratory failure and other systemic complications **Genetic Testing and Diagnosis:** * Muscle biopsy: to examine muscle tissue for signs of mitochondrial dysfunction * Genetic testing: to identify mutations in the mitochondrial DNA * Clinical evaluation: to assess symptoms and medical history ### Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and complexity. Affected individuals and their families often face significant challenges in terms of diagnosis, treatment, and management. Advances in genetic testing and molecular biology have improved our understanding of MM, but more research is needed to develop effective treatments and improve patient outcomes. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1960s (first reported cases) - Location: Worldwide - Known For: Complex and multifaceted group of disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Kearns-Sayre Syndrome, MERRF, NARP, Muscle weakness, Fatigue, Seizures, Neurological symptoms, Genetic disorders, Rare conditions. **Important Note:** If you or a family member is experiencing symptoms of Mitochondrial Myopathies, seek medical attention immediately. A diagnosis can only be made by a qualified healthcare professional, and early detection and treatment can improve patient outcomes.
Health & MedicineConditions Encyclopedia Entry 1775477045
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA (mtDNA). These disorders affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. Mitochondrial Myopathies are inherited in a maternal lineage, meaning they are passed down from mother to child. The symptoms and severity of MM can vary widely among individuals, depending on the specific mutation and the extent of mitochondrial dysfunction. Mitochondrial Myopathies are characterized by impaired energy production in cells, leading to muscle weakness, fatigue, and other systemic symptoms. The symptoms of MM can include muscle pain, weakness, and wasting, particularly in the muscles of the face, neck, and limbs. Other symptoms may include seizures, developmental delays, and visual and hearing impairments. In some cases, MM can lead to life-threatening complications, such as respiratory failure and cardiac arrest. ## History/Background Mitochondrial Myopathies were first described in the 1960s, when researchers identified a group of patients with muscle weakness and fatigue who had abnormal mitochondrial function. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying MM. In 1988, the first mitochondrial DNA mutation was identified as the cause of MM. Today, over 150 mitochondrial DNA mutations have been associated with MM, and researchers continue to explore the genetic and molecular mechanisms underlying these disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which is inherited from the mother. These mutations can occur in any of the 37 genes that encode proteins involved in energy production. The most common mutations associated with MM are those that affect the genes encoding for the respiratory chain complexes, which are essential for energy production in cells. Other key information about MM includes: * **Inheritance pattern:** Mitochondrial Myopathies are inherited in a maternal lineage, meaning they are passed down from mother to child. * **Symptoms:** Muscle weakness, fatigue, muscle pain, seizures, developmental delays, visual and hearing impairments. * **Diagnosis:** Diagnosis is based on a combination of clinical evaluation, genetic testing, and muscle biopsy. * **Treatment:** There is no cure for MM, but treatment options may include physical therapy, speech therapy, and medications to manage symptoms. ## Significance Mitochondrial Myopathies are a significant public health concern due to their rarity and severity. According to the National Institutes of Health (NIH), MM affects approximately 1 in 5,000 people worldwide. The significance of MM lies in its impact on individuals and families affected by the disorder. MM can have a profound impact on quality of life, leading to significant disability and mortality. Additionally, MM highlights the importance of understanding the genetic and molecular mechanisms underlying complex diseases, which can inform the development of new treatments and therapies. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorder - Date: First described in the 1960s - Location: Worldwide - Known For: Impaired energy production in cells leading to muscle weakness and fatigue **TAGS:** Mitochondrial Myopathies, Rare genetic disorders, Mitochondrial DNA, Energy production, Muscle weakness, Fatigue, Seizures, Developmental delays, Visual and hearing impairments.
Health & MedicineConditions Encyclopedia Entry 1779205399
** **Mitochondrial Myopathies** are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial Myopathies (MM) are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the mitochondria's ability to produce energy. Mitochondria are the powerhouses of cells, responsible for generating adenosine triphosphate (ATP), the primary energy source for cellular functions. In MM, the impaired energy production leads to muscle weakness, fatigue, and other systemic symptoms. These disorders can affect various organs and tissues, including the nervous system, heart, and gastrointestinal tract. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. The disorders can be classified into several subtypes, including: - **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)**: characterized by seizures, muscle weakness, and lactic acidosis. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: marked by myoclonic seizures, muscle weakness, and ragged-red fibers in muscle biopsies. - **Kearns-Sayre Syndrome (KSS)**: characterized by progressive external ophthalmoplegia, muscle weakness, and cardiac conduction abnormalities. - **Leigh Syndrome**: a severe disorder affecting the nervous system, characterized by seizures, muscle weakness, and developmental delays. ## History/Background The first reported case of Mitochondrial Myopathies dates back to 1963, when a British neurologist, John Walton, described a patient with a rare disorder characterized by muscle weakness, seizures, and lactic acidosis. However, it wasn't until the 1980s that the genetic basis of these disorders was identified. The discovery of mitochondrial DNA mutations in patients with MM marked a significant breakthrough in understanding the pathogenesis of these disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA that affect the expression of mitochondrial genes. These mutations can lead to impaired energy production, oxidative stress, and cellular damage. The disorders can be diagnosed through a combination of clinical evaluation, muscle biopsy, and genetic testing. Key features of Mitochondrial Myopathies include: - **Muscle weakness**: progressive muscle weakness, particularly in the proximal muscles. - **Fatigue**: persistent fatigue, even after rest. - **Lactic acidosis**: elevated levels of lactic acid in the blood. - **Seizures**: seizures, particularly in MELAS and MERRF subtypes. - **Developmental delays**: delayed development in children with Leigh Syndrome. ## Significance Mitochondrial Myopathies are rare disorders with significant impact on patients and their families. The disorders can be challenging to diagnose and manage, requiring a multidisciplinary approach involving neurologists, geneticists, and other specialists. Early diagnosis and treatment can improve quality of life and slow disease progression. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** First reported case in 1963 - **Location:** Global - **Known For:** Impaired energy production and systemic symptoms **TAGS:** Mitochondrial Myopathies, Mitochondrial DNA, Nuclear DNA, Energy production, Muscle weakness, Fatigue, Lactic acidosis, Seizures, Developmental delays, Rare genetic disorders.
Health & MedicineConditions Encyclopedia Entry 1782265948
Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1782506824
** A rare and complex neurological disorder characterized by abnormal electrical discharges in the brain, leading to seizures and other neurological symptoms. **CONTENT:** ## Overview **Epilepsy** is a chronic neurological disorder that affects millions of people worldwide. It is characterized by recurrent seizures, which can be caused by abnormal electrical discharges in the brain. These discharges can be triggered by various factors, including genetics, head injuries, infections, and certain medications. Epilepsy can manifest in different forms, ranging from mild to severe, and can affect people of all ages. While the exact cause of epilepsy is often unknown, research has made significant progress in understanding the underlying mechanisms and developing effective treatments. ## History/Background The earliest recorded descriptions of epilepsy date back to ancient civilizations, with the Egyptians, Greeks, and Romans all documenting cases of seizures and epilepsy-like symptoms. The Greek physician Hippocrates (460-370 BCE) is credited with being one of the first to describe epilepsy as a distinct medical condition. Throughout history, epilepsy has been associated with various superstitions and misconceptions, with many people believing that it was caused by demonic possession or evil spirits. It wasn't until the 19th century that epilepsy began to be understood as a neurological disorder, with the discovery of the electrical activity in the brain. ## Key Information **Epilepsy** is a complex condition that can manifest in different forms, including: * **Generalized seizures**: These are the most common type of seizure, affecting both sides of the brain and causing loss of consciousness, convulsions, and muscle spasms. * **Partial seizures**: These seizures affect only one part of the brain and can cause a range of symptoms, including numbness, tingling, and muscle weakness. * **Status epilepticus**: This is a life-threatening condition characterized by prolonged seizures or a series of seizures without full recovery between them. * **Epilepsy syndromes**: These are specific patterns of seizures that are often associated with specific causes, such as genetic mutations or brain injuries. ## Significance Epilepsy is a significant public health concern, affecting approximately 65 million people worldwide. While it is often associated with childhood, epilepsy can occur at any age, and it is estimated that 1 in 26 people will develop epilepsy in their lifetime. Epilepsy can have a profound impact on a person's quality of life, affecting their ability to work, drive, and engage in social activities. However, with the development of effective treatments, including medications, surgery, and lifestyle modifications, many people with epilepsy are able to manage their symptoms and lead active, fulfilling lives. **INFOBOX:** - Name: Epilepsy - Type: Neurological disorder - Date: Ancient civilizations ( earliest recorded descriptions) - Location: Global - Known For: Recurrent seizures and abnormal electrical discharges in the brain **TAGS:** Epilepsy, Neurological disorder, Seizures, Brain, Neurology, Medicine, Health, Neurological symptoms, Chronic condition. **Important Note:** If you or someone you know is experiencing seizures or other symptoms of epilepsy, it is essential to seek medical attention immediately. A healthcare professional can provide a proper diagnosis and develop a treatment plan to manage symptoms and improve quality of life.
Health & MedicineConditions Encyclopedia Entry 1782907685
** This encyclopedia entry provides a comprehensive overview of **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the muscles and energy production within cells. ## Overview Mitochondrial Myopathies (MMs) are a group of inherited disorders caused by mutations in the mitochondrial DNA. These conditions affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. MMs are characterized by their unique inheritance pattern, where the mutated gene is passed down from mother to child. This is because only egg cells contribute mitochondria to the developing embryo, making the disorder more prevalent in females. Mitochondrial Myopathies can manifest in various forms, including **Kearns-Sayre Syndrome**, **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**, and **Chronic Progressive External Ophthalmoplegia (CPEO)**. Each form has distinct clinical features, but they all share a common underlying cause: the disruption of normal mitochondrial function. The symptoms of MMs can vary widely, ranging from mild to severe, and may include muscle weakness, exercise intolerance, seizures, and vision problems. ## History/Background The first reported case of a mitochondrial myopathy dates back to 1957, when a British physician, **John Walton**, described a patient with a rare muscle disorder. However, it wasn't until the 1960s that the concept of mitochondrial inheritance began to take shape. The discovery of mitochondrial DNA in 1964 by **Barbara McClintock** and **John Cairns** laid the groundwork for understanding the genetic basis of MMs. In the 1980s, the first mitochondrial myopathy was identified as a distinct clinical entity, and since then, numerous studies have shed light on the molecular mechanisms underlying these disorders. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which is responsible for encoding genes involved in energy production. The most common mutations associated with MMs are point mutations, deletions, or duplications in the mitochondrial genome. These genetic alterations disrupt the normal functioning of the mitochondria, leading to a decrease in energy production and an accumulation of toxic byproducts. The symptoms of MMs can be managed through a combination of lifestyle modifications, medication, and physical therapy. Some key facts about Mitochondrial Myopathies include: * **Inheritance pattern**: MMs are inherited in a maternal lineage, meaning the mutated gene is passed down from mother to child. * **Prevalence**: MMs are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. * **Symptoms**: Muscle weakness, fatigue, seizures, vision problems, and exercise intolerance are common symptoms of MMs. * **Treatment**: There is no cure for MMs, but symptoms can be managed through a combination of lifestyle modifications, medication, and physical therapy. ## Significance Mitochondrial Myopathies are significant because they highlight the importance of understanding the genetic basis of human disease. The study of MMs has led to important advances in our understanding of mitochondrial function and the development of new treatments for related disorders. Furthermore, MMs serve as a reminder of the complex interplay between genetic and environmental factors that contribute to human disease. ## InfoBox: - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** First reported case in 1957 - **Location:** Worldwide - **Known For:** Unique inheritance pattern and disruption of mitochondrial function ## Tags: Mitochondrial Myopathies, Kearns-Sayre Syndrome, Myoclonic Epilepsy with Ragged-Red Fibers, Chronic Progressive External Ophthalmoplegia, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Seizures, Vision Problems, Exercise Intolerance, Genetic Disorders, Rare Diseases, Inherited Disorders, Maternal Lineage.
Health & MedicineConditions Encyclopedia Entry 1780609884
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which are responsible for producing energy for the cell. Mitochondrial Myopathies can affect various parts of the body, including the muscles, brain, and other organs. The symptoms of MM can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial Myopathies are a complex and heterogeneous group of disorders, with over 150 different mutations identified in the mitochondrial DNA. The most common forms of MM include Kearns-Sayre Syndrome (KSS), Myoclonic Epilepsy with Ragged-Red Fibers (MERRF), and Chronic Progressive External Ophthalmoplegia (CPEO). Each of these forms has distinct clinical features and prognoses. The diagnosis of Mitochondrial Myopathies is often challenging, as the symptoms can be nonspecific and overlap with other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ### History/Background The first reported case of Mitochondrial Myopathy was in 1957, when a 12-year-old boy was described with a rare condition characterized by progressive external ophthalmoplegia and muscle weakness. However, it wasn't until the 1960s and 1970s that the mitochondrial DNA was identified as the source of the mutations causing these disorders. In the 1980s, the first molecular genetic studies were conducted on Mitochondrial Myopathies, leading to the identification of several key mutations. The development of genetic testing and muscle biopsy techniques has greatly improved the diagnosis and management of MM. ### Key Information **Key Facts:** - **Prevalence:** Mitochondrial Myopathies are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people. - **Inheritance:** MM can be inherited in an autosomal dominant, autosomal recessive, or mitochondrial pattern. - **Symptoms:** Muscle weakness, fatigue, seizures, vision problems, and other systemic symptoms. - **Prognosis:** The prognosis varies depending on the specific form of MM, but most patients experience a gradual decline in function over time. **Key Achievements:** - **Genetic testing:** The development of genetic testing has greatly improved the diagnosis of MM. - **Muscle biopsy:** Muscle biopsy has become a crucial tool in the diagnosis and management of MM. - **Clinical trials:** Several clinical trials have been conducted to investigate the effectiveness of various treatments for MM. ### Significance Mitochondrial Myopathies are a significant public health concern, as they can have a profound impact on the quality of life of affected individuals and their families. The diagnosis and management of MM require a multidisciplinary approach, involving geneticists, neurologists, and other specialists. The study of Mitochondrial Myopathies has also led to a greater understanding of the role of mitochondria in human disease and has implications for the treatment of other conditions, such as neurodegenerative diseases and cancer. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** 1957 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Muscle Weakness, Fatigue, Seizures, Vision Problems, Genetic Testing, Muscle Biopsy, Clinical Trials, Multidisciplinary Approach.
Health & MedicineConditions Encyclopedia Entry 1780963685
** **Mitochondrial Myopathies** are a group of rare genetic disorders caused by mutations in the mitochondrial DNA, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a heterogeneous group of disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA (mtDNA), which is separate from the nuclear DNA found in the cell's nucleus. Mitochondrial myopathies can affect various systems in the body, including the muscles, nervous system, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, exercise intolerance, and other systemic symptoms. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a mutation in one copy of the mtDNA is sufficient to cause the condition. This is because mitochondrial DNA is inherited solely from the mother, and mutations in the mtDNA can be passed down through generations. Mitochondrial myopathies can affect individuals of any age, but symptoms often become apparent during childhood or adolescence. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to recognize the importance of mitochondrial function in cellular energy production. In the 1980s, the discovery of mtDNA mutations led to a greater understanding of the genetic basis of mitochondrial myopathies. Since then, numerous studies have shed light on the molecular mechanisms underlying these conditions, leading to the development of new diagnostic and therapeutic strategies. ## Key Information Mitochondrial myopathies are caused by mutations in the mtDNA, which can lead to impaired energy production in cells. The most common types of mitochondrial myopathies include: * **Myoclonic epilepsy with ragged-red fibers (MERRF)**: characterized by muscle weakness, seizures, and other systemic symptoms. * **Kearns-Sayre syndrome (KSS)**: a rare condition that affects the muscles, nervous system, and other organs. * **Chronic progressive external ophthalmoplegia (CPEO)**: a condition that affects the muscles controlling eye movement. * **Leigh syndrome**: a severe condition that affects the brain, muscles, and other organs. Symptoms of mitochondrial myopathies can vary widely, but often include: * Muscle weakness and fatigue * Exercise intolerance * Numbness or tingling in the hands and feet * Seizures * Vision problems * Hearing loss * Cardiac arrhythmias ## Significance Mitochondrial myopathies are a significant cause of morbidity and mortality worldwide. These conditions can have a profound impact on an individual's quality of life, leading to significant disability and reduced life expectancy. However, advances in diagnostic and therapeutic strategies have improved outcomes for individuals with mitochondrial myopathies. ## INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting muscle function and energy production ## TAGS: Genetic disorder, Mitochondrial disease, Muscle weakness, Fatigue, Exercise intolerance, Seizures, Vision problems, Hearing loss, Cardiac arrhythmias